John Patrick Alao
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 9
- Histone Deacetylase Inhibitors Research 8
- Fungal and yeast genetics research 6
- Ubiquitin and proteasome pathways 5
- Epigenetics and DNA Methylation 4
-
- Bioactive Compounds and Antitumor Agents 4
- Co-authors
- Per Sunnerhagen (18 shared papers)Raoul Charles Coombes (9 shared papers)David M. Vigushin (9 shared papers)Eric W.‐F. Lam (6 shared papers)Alexandra V. Stavropoulou (5 shared papers)Peter Dinér (4 shared papers)Simak Ali (3 shared papers)Morten Grøtli (3 shared papers)
- Journals
- Molecular Cancer (4 papers)Molecular Microbiology (3 papers)Molecules (2 papers)Cells (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
- Partner nations
- SwedenUnited KingdomKenya
In The Last Decade
John Patrick Alao
33 papers receiving 1.6k citations
John Patrick Alao's Hit Papers
Peers
Comparison fields: 5 of 95
- Toxicology 63
- Oncology 376
- Cancer Research 195
- Molecular Biology 969
- Complementary and alternative medicine 54
Countries citing papers authored by John Patrick Alao
This map shows the geographic impact of John Patrick Alao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Patrick Alao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Patrick Alao more than expected).
Fields of papers citing papers by John Patrick Alao
This network shows the impact of papers produced by John Patrick Alao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Patrick Alao. The network helps show where John Patrick Alao may publish in the future.
Co-authors
The 25 scholars most cited alongside John Patrick Alao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention Hit paper breakdown → | 2007 | 721 |
| 2 | 2004 | 106 | |
| 3 | 2004 | 79 | |
| 4 | 2006 | 77 | |
| 5 | 2006 | 65 | |
| 6 | 2004 | 62 | |
| 7 | 2006 | 61 | |
| 8 | 2011 | 53 | |
| 9 | 2012 | 44 | |
| 10 | 2014 | 44 | |
| 11 | 2009 | 42 | |
| 12 | 2006 | 39 | |
| 13 | 2009 | 29 | |
| 14 | 2004 | 28 | |
| 15 | 2011 | 25 | |
| 16 | 2014 | 22 | |
| 17 | 2012 | 22 | |
| 18 | 2023 | 20 | |
| 19 | 2006 | 18 | |
| 20 | 2012 | 18 |
About John Patrick Alao
John Patrick Alao is a scholar working on Molecular Biology, Toxicology, Complementary and alternative medicine, Aging and Oncology, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (9 papers), Histone Deacetylase Inhibitors Research (8 papers), Fungal and yeast genetics research (6 papers), Ubiquitin and proteasome pathways (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer-related Molecular Pathways (4 papers), Synthesis and biological activity (4 papers) and Bioactive Compounds and Antitumor Agents (4 papers). The work is most often cited by research in Toxicology (63 citations), Oncology (376 citations), Cancer Research (195 citations), Molecular Biology (969 citations) and Complementary and alternative medicine (54 citations). John Patrick Alao has collaborated with scholars based in Sweden, United Kingdom and Kenya. Frequent co-authors include Per Sunnerhagen, Raoul Charles Coombes, David M. Vigushin, Eric W.‐F. Lam, Alexandra V. Stavropoulou, Peter Dinér, Simak Ali, Morten Grøtli, Rana Varshochi and Abiy Yenesew. Their work appears in journals such as Molecular Cancer, Molecular Microbiology, Molecules, Cells and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.